|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||
| Current assets | ||||||||||
| Cash | ||||||||||
| Due from Sponsor | ||||||||||
| Prepaid expenses | ||||||||||
| Total Current Assets | ||||||||||
| Deferred offering costs | ||||||||||
| Long-term prepaid insurance | ||||||||||
| Marketable securities held in Trust Account | ||||||||||
| Total Assets | ||||||||||
| LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT | ||||||||||
| Current liabilities | ||||||||||
| Accrued offering costs | ||||||||||
| Accrued expenses | ||||||||||
| Advance from related party | ||||||||||
| Promissory note – related parties | ||||||||||
| Related Party | ||||||||||
| Total promissory note – related parties | ||||||||||
| Total Current Liabilities | ||||||||||
| Deferred legal fee | ||||||||||
| Deferred underwriting fee payable | ||||||||||
| Total Liabilities | ||||||||||
| Class A ordinary shares subject to possible redemption, 8,973,728 and 28,750,000 shares at redemption value of $10.95 and $10.75 per share as of June 30, 2026 and December 31, 2025, respectively | ||||||||||
| Class A | ||||||||||
| Total class A ordinary shares subject to possible redemption, 8,973,728 and 28,750,000 shares at redemption value of $10.95 and $10.75 per share as of June 30, 2026 and December 31, 2025, respectively | ||||||||||
| Shareholders’ Deficit | ||||||||||
| Class ordinary shares ,value | ||||||||||
| Additional paid-in capital | ||||||||||
| Accumulated deficit | ||||||||||
| Total Shareholders’ Deficit | ||||||||||
| Total Liabilities, Class A ordinary shares subject to Possible Redemption, and Shareholders’ Deficit |
Loading...
